(Q40736811)

English

P-glycoprotein-170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytes

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

P-glycoprotein-170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Farrell RJ

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Menconi MJ

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Keates AC

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Kelly CP

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1021-1031

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Frequency of glucocorticoid resistance and dependency in Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

The P-glycoprotein multidrug transporter

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

Multidrug resistance activity in human lymphocytes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

Epithelial secretion of vinblastine by human intestinal adenocarcinoma cell (HCT-8 and T84) layers expressing P-glycoprotein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

Effect of the multidrug resistance modulator valspodar on serum cortisol levels in rabbits

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

MDR1 gene expression in brain of patients with medically intractable epilepsy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

Frequency of C3435T polymorphism of MDR1 gene in African people

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

Expression of a multidrug-resistance gene in human tumors and tissues

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

Low-Dose Cyclosporine for the Treatment of Crohn's Disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01238.X

21 January 2018

Identifiers

10.1046/J.1365-2036.2002.01238.X

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40736811&oldid=1906297002"